Insulin Sensitivity and Beta Cell Function After Carbohydrate Loading in Hip Replacement Surgery
Primary Purpose
Insulin Sensitivity
Status
Completed
Phase
Phase 4
Locations
Sweden
Study Type
Interventional
Intervention
Experimental: PreOp, NutriciaNordica AB
Placebo Comparator: Water
Sponsored by
About this trial
This is an interventional treatment trial for Insulin Sensitivity focused on measuring Insulin sensitivity, Beta cell function, Carbohydrate preload, Elective hip replacement, Double-blind randomized control study
Eligibility Criteria
Inclusion Criteria:
- Elective hip replacement
Exclusion Criteria:
- Known diabetes mellitus
- Kidney failure (creatinine clearance <40 ml/min
- Liver failure (aspartate and alanine aminotransferases x 2 above reference)
- Hb <110 g/l
- Ongoing severe bacterial or viral infection
- Malignancies
- Psychiatric disease
Sites / Locations
- Södersjukhuset AB
- Södertälje hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
PreOp, NutriciaNordica AB
Water
Arm Description
PreOp: 50 kcal/100 mL in the form of maltodextrin and fructose. One bottle of 800 ml to be ingested at bedtime, and at midnight by the latest, and another bottle with 400 ml approximately 2 hours before surgery started.
Water: One bottle of 800 ml to be ingested at bedtime, and at midnight by the latest, and another bottle with 400 ml approximately 2 hours before surgery started.
Outcomes
Primary Outcome Measures
Change in Insulin Sensitivity
Insulin sensitivity is measured by euglycemic hyperinsulinemic clamp
Secondary Outcome Measures
Change in Beta Cell Function
Beta cell function is measured with intravenous glucose tolerance test (IVGTT)
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01774084
Brief Title
Insulin Sensitivity and Beta Cell Function After Carbohydrate Loading in Hip Replacement Surgery
Official Title
Insulin Sensitivity and Beta Cell Function After Carbohydrate Loading in Hip Replacement Surgery: A Randomised Doubled-blinded Control Study
Study Type
Interventional
2. Study Status
Record Verification Date
June 2014
Overall Recruitment Status
Completed
Study Start Date
January 2012 (undefined)
Primary Completion Date
February 2013 (Actual)
Study Completion Date
March 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Karolinska Institutet
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to determine whether preload of carbohydrate or water before elective hip replacement improve insulin sensitivity and or beta cell function in human.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Insulin Sensitivity
Keywords
Insulin sensitivity, Beta cell function, Carbohydrate preload, Elective hip replacement, Double-blind randomized control study
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
23 (Actual)
8. Arms, Groups, and Interventions
Arm Title
PreOp, NutriciaNordica AB
Arm Type
Active Comparator
Arm Description
PreOp: 50 kcal/100 mL in the form of maltodextrin and fructose. One bottle of 800 ml to be ingested at bedtime, and at midnight by the latest, and another bottle with 400 ml approximately 2 hours before surgery started.
Arm Title
Water
Arm Type
Placebo Comparator
Arm Description
Water: One bottle of 800 ml to be ingested at bedtime, and at midnight by the latest, and another bottle with 400 ml approximately 2 hours before surgery started.
Intervention Type
Dietary Supplement
Intervention Name(s)
Experimental: PreOp, NutriciaNordica AB
Other Intervention Name(s)
PreOp, serial number 27 62 95, NutriciaNordica AB
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo Comparator: Water
Primary Outcome Measure Information:
Title
Change in Insulin Sensitivity
Description
Insulin sensitivity is measured by euglycemic hyperinsulinemic clamp
Time Frame
Morning before surgery and up to two days after surgery
Secondary Outcome Measure Information:
Title
Change in Beta Cell Function
Description
Beta cell function is measured with intravenous glucose tolerance test (IVGTT)
Time Frame
Morning before surgery and up to two days after surgery
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Elective hip replacement
Exclusion Criteria:
Known diabetes mellitus
Kidney failure (creatinine clearance <40 ml/min
Liver failure (aspartate and alanine aminotransferases x 2 above reference)
Hb <110 g/l
Ongoing severe bacterial or viral infection
Malignancies
Psychiatric disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thomas Nyström, MD
Organizational Affiliation
Karolinska Institutet
Official's Role
Principal Investigator
Facility Information:
Facility Name
Södersjukhuset AB
City
Stockholm
ZIP/Postal Code
116 48
Country
Sweden
Facility Name
Södertälje hospital
City
Södertälje
ZIP/Postal Code
15286
Country
Sweden
12. IPD Sharing Statement
Citations:
PubMed Identifier
24007934
Citation
Ljunggren S, Hahn RG, Nystrom T. Insulin sensitivity and beta-cell function after carbohydrate oral loading in hip replacement surgery: a double-blind, randomised controlled clinical trial. Clin Nutr. 2014 Jun;33(3):392-8. doi: 10.1016/j.clnu.2013.08.003. Epub 2013 Aug 15.
Results Reference
derived
Links:
URL
http://www-ncbi-nlm-nih-gov.proxy.kib.ki.se/pubmed/24007934
Description
Related Info
Learn more about this trial
Insulin Sensitivity and Beta Cell Function After Carbohydrate Loading in Hip Replacement Surgery
We'll reach out to this number within 24 hrs